Substance Misuse Testing Services - AWARD

The Civil Nuclear Constabulary has concluded the tender process for Substance Misuse Testing Services with an awarded contract valued at £160,000. This procurement falls under the medical practice and related services industry category, adhering to the NHS SB Framework 10241 for Drugs of Abuse and Point of Care Testing as per PCR2015 guidelines. The contract was awarded to Abbott Toxicology Ltd, following the framework's detailed procedures and market testing.

The contracting phase commenced on 1st April 2025 and will extend until 31st March 2029, covering locations in the United Kingdom and other international regions specified. This direct award marks the completion of the procurement process. Businesses specialising in medical practice services, particularly those focusing on substance misuse testing, have the opportunity to explore growth and partnerships in this sector.

Although the suitability criteria did not specifically target SMEs or VCSEs, organisations with robust capabilities in medical testing can gain significant insights and competitive advantage by aligning with similar NHS frameworks and procurement methods in future tender opportunities. This contract demonstrates the demand for specialised testing services in Channel Islands, Isle of Man, and British Overseas Territories, presenting a strategic avenue for expansion and increased market footprint. Potential competitors should assess their service offerings to meet the precise needs outlined in government frameworks.